Independent peptide education

Evidence Standards

Quick answer: We rank claims by the strongest directly relevant evidence available, not by repetition online. FDA labeling and regulatory databases establish approval status. Registered trials show what is being studied. Peer-reviewed human trials can inform effectiveness and safety, while animal and laboratory studies mainly generate hypotheses.

Our evidence ladder

1. FDA-approved labeling and databasesBest source for approved indications, dosage forms, warnings, contraindications, and product status.
2. Systematic reviews and high-quality human trialsUseful when methods, population, comparator, endpoints, and limitations are clear.
3. Registered clinical trialsShows active investigation, not proven benefit or approval.
4. Observational reports and case seriesCan identify signals but cannot reliably establish cause and effect.
5. Animal and laboratory researchMechanistic and exploratory evidence that may not translate to people.
6. Testimonials and seller claimsCommercial anecdotes are not reliable evidence of typical results or safety.

Information gain over recycled summaries

Every profile should answer: What is actually approved? What is being studied? What evidence is missing? What category mistakes are common? Which official source can verify the claim? If a page cannot add those distinctions, it is not ready to publish.

Updates and corrections

Regulatory status can change. Each profile includes a review date and source list. Material corrections are logged through WordPress revisions. A named medical reviewer is displayed only after a real person has reviewed that specific page.

How we handle conflicting evidence

When high-quality sources disagree, we describe the disagreement rather than choosing the most promotional conclusion. Differences may come from population, dose, outcome definition, follow-up, statistical method, or product formulation.

How we handle animal and cell research

Preclinical evidence is labeled explicitly and is not written as a clinical recommendation. We explain the research question and why translation to people remains uncertain.

How we handle absence of evidence

\u201cNo adequate evidence\u201d does not prove a compound has no effect. It means confident benefit and safety claims are not justified. The editorial conclusion should match the evidence available today.

Commercial claims require the same standard

Affiliate compensation does not lower the evidence threshold. Objective health claims require reliable substantiation, and disclosures cannot cure a false or misleading claim.

Review checklist before publication

  • Status confirmed in an official database
  • Primary sources opened and read
  • Human and preclinical evidence separated
  • Product-formulation match checked
  • Risks and limitations included
  • Internal links connect related concepts
  • Commercial relationship disclosed

Study design details we report

When discussing human evidence, we identify randomization, comparator, blinding, sample size, duration, population, primary endpoint, discontinuation, and material limitations when available.

Statistical significance versus practical importance

A statistically detectable difference may be small, short-lived, or based on a surrogate outcome. We avoid presenting a p-value as proof of meaningful benefit.

Corrections and version control

WordPress revisions preserve changes. Major regulatory or safety updates should include a visible updated date and a note when an earlier conclusion changed.